Three Dimensional Measurement of the Space Distance Between the Hilum and Clinical Stage T1 Non-small Cell Lung Cancer and Its Relationship with Lymph Node Metastasis

LI Gang, DENG Han-yu, LUO Jun , WANG Yun-cang, ALAIGUHA, ZHUO Ze-guo, SHEN Xu, LIN Yi-dan

Abstract

The aim of this study was to develop a novel method to quantitatively define the tumor location of clinical stage T1 (cT1) non-small cell lung cancer (NSCLC) and to evaluate its impact on lymph node metastasis in a large cohort group.  Methods  We developed a novel method to transform the datum of 2D CT scans to 3D datum and to quantitatively measure the distance between the tumor and hilum through the Pythagorean theorem. Multiple logistic regression analysis was applied to identify the risk factors associated with lymph node metastasis.  Results  A total of 399 patients (166 male and 233 female) with cT1 NSCLC were enrolled in this study. The mean age was (57.48±10.88) yr., the mean distance between tumor and hilum was (5.44±1.96) cm, and the mean tumor diameter was (1.77±0.65) cm. Patients were divided into lymph node positive group (N+ group) and lymph node negative group (N－ group). By multiple logistic regression analysis, we identified 4 risk variables associated with lymph node metastasis. Gender (odds ratio (OR)=2.118, P=0.022), distance between tumor and hilum (OR=0.843, P=0.040), differentiation (moderate vs. high, OR=15.547, P=0.008; poor vs. high, OR=70.749, P=0.000), and cancer embolus (OR=24.769, P=0.004) were independent risk variables associated with lymph node metastasis.  Conclusion  Distance between tumor and hilum was identified as an independent risk factor associated with lymph node metastasis in cT1 NSCLC.

 

Keywords: Non-small cell lung cancer, Computed tomography, Tumor localization, Lymph nodes metastasis

 

Full Text:

PDF


References


TORRE L A， SIEGEL R L， JEMAL A. Lung cancer statistics. Adv Exp Med Biol，2016，893: 1–19.

CASAL R， VIAL M， MILLER R， et al. What exactly is a centrally located lung tumor? Results of an online survey. Ann Am Thorac Soc，2017， 14(1): 118–123.

DECALUWE H， MOONS J， FIEUWS S， et al. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography? Eur J Cardiothorac Surg，2018，54(1): 134–140.

PARK H S， HARDER E M， MANCINI B R， et al. Central versus peripheral tumor location: influence on survival, local control, and toxicity following stereotactic body radiotherapy for primary non-small-cell lung cancer. J Thorac Oncol，2015，10(5): 832–837.

LIU C， GUO C， GAN F， et al. Results of video-assisted thoracic surgery versus thoracotomy in surgical resection of pN2 non-small cell lung cancer in a Chinese high-volume center. Surg Endosc， 2020[2020-05-16]. https://link.springer.com/article/10.1007/s00464-020-07624-2. doi: 10.1007/s00464-020-07624-2.

GOLDSTRAW P， CHANSKY K， CROWLEY J， et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol，2016，11(1): 39–51.

WAN Y， CAROLE A R， ANDREW G N， et al. The 8(th) lung cancer TNM classification and clinical staging system: review of the changes and clinical implications. Quant Imaging Med Surg，2018，8(7): 709–718.

XIONG J， WANG R， SUN Y， et al. Clinical analysis of sixty-four patients with T1aN2M0 stage non-small cell lung cancer who had undergone resection. Thorac Cancer，2016，7(2): 215–221.

ZANG R C， QIU B， GAO S G， et al. A model predicting lymph node status for patients with clinical stage T1aN0-2M0 nonsmall cell lung cancer. Chin Med J (Engl)，2017，130(4): 398–403.

KETCHEDJIAN A， DALY B， FERNANDO H C， et al. Location as an important predictor of lymph node involvement for pulmonary adenocarcinoma. J Thorac Cardiovasc Surg，2006，132(3): 544–548.

FARJAH F， LOU F， SIMA C， et al. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography. J Thorac Oncol，2013，8(9): 1170–1180.

KUZUCUOGLU M， GOKYER A， KULA O， et al. Relationship between the size and location of the mass and hilar and mediastinal lymph node metastasis in early ang locally advanced non-small cell lung cancer. J Coll Physicians Surg Park，2020，30(2): 172–176.

ANGUIANO M， CASTILLA C， MASKA M， et al. Characterization of three-dimensional cancer cell migration in mixed collagen—Matriged scaffolds using microfluidics and image analysis. PLoS One， 2017， 12(2): e0171417[2020-05-16]. https://doi.org/10.1371/journal.pone.0171417.

HUANG X， YUE S， WANG C， et al. Optimal three-dimensional reconstruction for lung cancer tissues. Technol Health Care，2017，25(S1): 423–434.

YUSHIDA Y， MANAKA T， NITADORI J， et al. A comparison between 2- and 3-dimensional approaches to solid component measurement as radiological criteria for sublobar resection in lung adenocarcinoma ≤ 2 cm in size. Surg Today，2019，49(10): 828–835.

FALKSON C， VELLA E， YU E， et al. Guideline for radiotherapy with curative intent in patient with early-stage medically inoperable non-small-cell lung cancer. Curr Oncol，2017，24(1): e44–e49.

MIX M， TANNY S， NSOULI T， et al. Outcomes following stereotactic body radiotherapy with intensity-modulated therapy versus three-dimensional conformal radiotherapy in early stage non-small cell lung cancer. Lung Cancer (Auckl)，2019，10: 151–159.

ARDILA D， KIRALY A， BHARADWAJ S， et al. End-to end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med，2019，25(6): 954–961.

KITAZAWA S， SAEKI Y， KOBAYASHI N， et al. Three-dimensional mean CT attenuation value of pure and part-solid ground-glass lung nodules may predict invasiveness in early adenocarcinoma. Clin Radiol， 2019，74(12): 944–949.

TSUTANI Y， MURAKAMI S， MIYATA Y， et al. Prediction of lymph node status in clinical stage ⅠA squamous cell carcinoma of the lung. Eur J Cardiothorac Surg，2015，47(6): 1022–1026.

ZHANG S， LI S， PEI Y， et al. Impact of maximum standardized uptake value of non-small cell lung cancer on detecting lymph node involvement in potential stereotactic body radiotherapy candidates. J Thorac Dis， 2017，9(4): 1023–1031.


Refbacks

  • There are currently no refbacks.